Researchers observe an increased risk of cancer in people with history of non-melanoma skin cancer

April 23, 2013

Boston, MA - A prospective study by researchers at Brigham and Women's Hospital (BWH) observed an association between risk of second primary cancer and history of non-melanoma skin cancer in white men and women.

The researchers found that people with a history of non-melanoma skin cancer had a modestly increased risk of getting cancer in the future, specifically breast and lung cancer in women and melanoma in both men and women. Non-melanoma skin cancer, which includes basal cell and squamous cell carcinoma, is the most common form of cancer in the United States.

The study will be published on April 23, 2013 in PLOS Medicine.

The researchers analyzed data from two large United States cohort studies--the Health Professionals Follow-up Study and the Nurses' Health Study. The researchers followed 46,237 men from June 1986 to June 2008 in the Health Professionals Follow-up Study, and 107,339 women from June 1984 to June 2008 in the Nurses' Health Study. The researchers identified 36,102 new cases of non-melanoma skin cancer and 29,447 new cases of other primary cancers.

A history of non-melanoma skin cancer was significantly associated with a 15 percent higher risk of other primary cancers in men, and a 26 percent higher risk of other primary cancers in women. When melanoma was excluded from this analysis, the rates changed slightly, with a history of non-melanoma skin cancer associated with an 11 percent higher risk of other primary cancers in men, and a 20 percent higher risk of other primary cancers in women.

After using statistical models to correct for multiple comparisons, looking at individual cancer sites, the researchers found that a history of non-melanoma skin cancer was significantly linked to an increased risk of breast and lung cancer in women, and an increased risk of melanoma in both men and women.

According to the researchers, these findings should be interpreted cautiously.

"Because our study was observational, these results should be interpreted cautiously and are insufficient evidence to alter current clinical recommendations," said Jiali Han, PhD, Channing Division of Network Medicine, BWH Department of Medicine and BWH Department of Dermatology. "Nevertheless, these data support a need for continued investigation of the potential mechanisms underlying this relationship."
-end-
This research was supported by the National Institutes of Health (CA87969 and CA055075).

Brigham and Women's Hospital

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.